Penserra Capital Management LLC Has $1.15 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Penserra Capital Management LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 147.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,320 shares of the company's stock after buying an additional 1,979 shares during the period. Penserra Capital Management LLC's holdings in HCA Healthcare were worth $1,146,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare during the first quarter worth approximately $28,000. Bartlett & CO. Wealth Management LLC boosted its position in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the period. Tidemark LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth approximately $36,000. ORG Partners LLC raised its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Legacy Investment Solutions LLC raised its holdings in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on HCA shares. Royal Bank Of Canada reissued an "outperform" rating and set a $404.00 target price (up previously from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Guggenheim assumed coverage on HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird restated a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research report on Monday, June 9th. Seven research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

HCA Healthcare Stock Down 0.9%

Shares of HCA Healthcare stock traded down $3.47 on Thursday, hitting $374.97. 558,171 shares of the company traded hands, compared to its average volume of 1,588,967. The company has a 50-day moving average price of $373.87 and a 200 day moving average price of $340.71. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market cap of $90.21 billion, a PE ratio of 16.67, a PEG ratio of 1.30 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the previous year, the business earned $5.36 EPS. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.77%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.